252 related articles for article (PubMed ID: 27418398)
21. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
Zhu Q; He P; Zheng C; Chen Z; Qi S; Zhou D; Li Y; Ouyang Q; Zi H; Tang H; Xing J; Xie Y; Zhu S; Ren J; Huang J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8369-8378. PubMed ID: 37079049
[TBL] [Abstract][Full Text] [Related]
22. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients.
Panigrahi GK; Praharaj PP; Kittaka H; Mridha AR; Black OM; Singh R; Mercer R; van Bokhoven A; Torkko KC; Agarwal C; Agarwal R; Abd Elmageed ZY; Yadav H; Mishra SK; Deep G
Cancer Med; 2019 Mar; 8(3):1110-1123. PubMed ID: 30623593
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
24. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
25. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
[TBL] [Abstract][Full Text] [Related]
26. Dual monoclonal antibody immunoassay for free prostate-specific antigen.
Wang TJ; Hill TM; Sokoloff RL; Frankenne F; Rittenhouse HG; Wolfert RL
Prostate; 1996 Jan; 28(1):10-6. PubMed ID: 8545276
[TBL] [Abstract][Full Text] [Related]
27. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin B expression is similar in African-American and Caucasian prostate cancer patients.
Sinha AA; Morgan JL; Buus RJ; Ewing SL; Fernandes ET; Le C; Wilson MJ
Anticancer Res; 2007; 27(5A):3135-41. PubMed ID: 17970054
[TBL] [Abstract][Full Text] [Related]
29. Association of serum EPCA-2 level with prostate cancer in Chinese Han population.
Wang L; Ma L; Wang X; Li B; Guo S; Qiao Q
Int J Clin Exp Pathol; 2015; 8(8):9397-403. PubMed ID: 26464694
[TBL] [Abstract][Full Text] [Related]
30. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
31. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
[TBL] [Abstract][Full Text] [Related]
33. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
34. Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer.
Coelho FF; Guimarães FL; Cabral WL; Salles PG; Mateo EC; Nogueira e Nogueira LM; Fonseca CE; Gomes KB
Genet Mol Res; 2015 Oct; 14(4):13519-31. PubMed ID: 26535666
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].
Popov SV; Guseinov RG; Skryabin ON; Orlov IN; Martov AG
Urologiia; 2018 Jul; (3):92-97. PubMed ID: 30035426
[TBL] [Abstract][Full Text] [Related]
36. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
[TBL] [Abstract][Full Text] [Related]
37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
38. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).
Lokant MT; Naz RK
Andrologia; 2015 Apr; 47(3):328-32. PubMed ID: 24620795
[TBL] [Abstract][Full Text] [Related]
39. BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.
Siddique HR; Parray A; Zhong W; Karnes RJ; Bergstralh EJ; Koochekpour S; Rhim JS; Konety BR; Saleem M
PLoS One; 2013; 8(1):e52993. PubMed ID: 23308129
[TBL] [Abstract][Full Text] [Related]
40. Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Li J; Veltri RW; Yuan Z; Christudass CS; Mandecki W
PLoS One; 2015; 10(4):e0122249. PubMed ID: 25853582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
